Myriad Genetics, Inc. (LON:0K3W)
7.48
-0.01 (-0.10%)
At close: Sep 12, 2025
Myriad Genetics Revenue
Myriad Genetics had revenue of $213.10M USD in the quarter ending June 30, 2025, with 0.76% growth. This brings the company's revenue in the last twelve months to $832.90M, up 3.83% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.
Revenue (ttm)
$832.90M
Revenue Growth
+3.83%
P/S Ratio
0.82
Revenue / Employee
$308.48K
Employees
2,700
Market Cap
497.10M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 837.60M | 84.40M | 11.21% |
Dec 31, 2023 | 753.20M | 74.80M | 11.03% |
Dec 31, 2022 | 678.40M | -12.20M | -1.77% |
Dec 31, 2021 | 690.60M | 133.60M | 23.99% |
Dec 31, 2020 | 557.00M | -81.60M | -12.78% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Myriad Genetics News
- 26 days ago - ANGLE plc partners with Myriad Genetics to advance cancer diagnostics - Seeking Alpha
- 4 weeks ago - Myriad Genetics announces CFO appointment - Seeking Alpha
- 4 weeks ago - Myriad Genetics Appoints Ben Wheeler Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results - GlobeNewsWire
- 5 weeks ago - Myriad: HCT In Oncology Continues To Deliver Increased Volume And Revenue Growth - Seeking Alpha
- 5 weeks ago - Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday - Benzinga
- 5 weeks ago - Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Benzinga
- 5 weeks ago - Myriad Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha